CompaniesGenova Clinical Research

Genova Clinical Research

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (23)
View all

Total Trials

23

As Lead Sponsor

2

As Collaborator

21

Total Enrollment

3,766

By Phase

PHASE1: 7NA: 4PHASE2: 7EARLY_PHASE1: 1PHASE1/PHASE2: 1PHASE3: 2

By Status

COMPLETED: 11WITHDRAWN: 4TERMINATED: 3RECRUITING: 2UNKNOWN: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline23 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT00038727
NCT01666353
NCT02112032
NCT02334735
NCT05629546
Hover over trial bars to see details

Recent Trials

NCT04119024Collaborator
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
PHASE1Recruiting
18 participants
Started: Oct 7, 2025 · Completed: Oct 31, 2026
NCT06758778Collaborator
CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions
NAEnrolling by invitation
14 participants
Started: Jan 3, 2025 · Completed: Mar 31, 2025
NCT05629546Collaborator
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors
PHASE1Recruiting
33 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2030
NCT06236984Collaborator
Retrospective Data Analysis of CKRT (Continuous Kidney Replacement Therapy) Treatments in Adult Mode With multiFiltratePRO
N/ACompleted
80 participants
Started: May 1, 2024 · Completed: Feb 21, 2025
NCT05201001Collaborator
APX005M in Patients With Recurrent Ovarian Cancer
PHASE2Withdrawn
Started: Sep 7, 2023 · Completed: Sep 7, 2023
View all 23 trials →